Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Tandem Diabetes Care, Inc.

United States·US-MF-000031791

Last updated September 17, 2026

Information

Country
United States
Address
12400 High Bluff Drive, San Diego, United States
LinkedIn
—
Facebook
—
Phone
877-801-6901
PRRC Contact
—
EUDAMED SRN
US-MF-000031791
FDA FEI Number
3013756811
DUNS Number
827900809

Catalogue (150)

Page 1 of 3
DeviceModel / ReferenceRegistriesClassStatus
Tandem t:slim AutoSoft XC Kit 1017083
FDA UDI
Class IIActive
t:slim X2 Cartridge, t:lock, 2 Pack 1000728
FDA UDI
Class IIIActive
t:flex Insulin Pump, Replacement, Refurbished 007473
FDA UDI
Class IIActive
Tandem t:slimTruSteel Kit 1017101
FDA UDI
Class IIActive
t:slim Insulin Pump, Demonstration 007445
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Control-IQ 1009643
FDA UDI
Class IIActive
Tandem Mobi Autosoft 30 Kit 1014121
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Basal-IQ 1009640
FDA UDI
Class IIActive
t:flex Cartridge 2 Pack 007689
FDA UDI
Class IIActive
t:slim Cartridge 10 Pack 003380
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Basal-IQ 1006373
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Control-IQ 1005011
FDA UDI
Class IIActive
Tandem Mobi Autosoft 30 Kit 1013121
FDA UDI
Class IIActive
t:slim G4 Cartridge 2 Pack 007527
FDA UDI
Class IIIActive
t:slim Cartridge, t:lock, 2 Pack 1000992
FDA UDI
Class IIActive
t:slim Insulin Pump 007435
FDA UDI
Class IIActive
t:slim Cartridge, t:lock, 10 Pack 1000991
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Control-IQ 1005012
FDA UDI
Class IIActive
t:slim Mobile Application, iOS 1014707
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Basal-IQ 1009639
FDA UDI
Class IIActive
Tandem Mobi Cartridge 1007737
FDA UDI
Class IIActive
t:slim G4 Insulin Pump with Dexcom G4 Platinum CGM 006194
FDA UDI
Class IIIActive
t:slim X2 Insulin Pump with Control-IQ+ Technology 1014071
FDA UDI
Class IIActive
t:slim G4 Insulin Pump, Reconditioned 008542
FDA UDI
Class IIIActive
Tandem t:slim Mobile Application, Android 1014706
FDA UDI
Class IIActive
t:flex Insulin Pump, Reconditioned 007666
FDA UDI
Class IIActive
t:slim G4 Cartridge 10 Pack 007526
FDA UDI
Class IIIActive
t:slim Insulin Pump, Reconditioned Replacement 007262
FDA UDI
Class IIActive
Tandem Mobi Adhesive Sleeve 1010123
FDA UDI
Class IActive
t:connect Mobile Application (Android) 1004127
FDA UDI
Class IIActive
t:slim Cartridge 2 Pack 006638
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Control-IQ Technology 1012868
FDA UDI
Class IIActive
Tandem Mobi Mobile Application 1015233
FDA UDI
Class IIActive
Tandem Mobi Autosoft XC Kit 1014119
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Basal-IQ 1000886
FDA UDI
Class IIIActive
Tandem t:slim Autosoft 30 kit 1017076
FDA UDI
Class IIActive
t:connect Mobile Application, Mobile Bolus Enabled (Android) 1007112
FDA UDI
Class IIActive
t:flex Insulin Pump, Replacement 007516
FDA UDI
Class IIActive
t:connect Mobile Application (iOS) 1004128
FDA UDI
Class IIActive
t:flex Cartridge, t:lock, 10 Pack 1001390
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Basal-IQ 1000892
FDA UDI
Class IIIActive
t:slim X2 Insulin Pump with Basal-IQ 1005698
FDA UDI
Class IIIActive
Tandem Mobi Autosoft XC Kit 1013119
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Basal-IQ 1006379
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Control-IQ 1006404
FDA UDI
Class IIActive
t:slim X2 Insulin Pump 1000103
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Control-IQ 1009637
FDA UDI
Class IIActive
Tandem Mobi TruSteel Kit 1013122
FDA UDI
Class IIActive
Tandem t:slim Autosoft 30 kit 1017089
FDA UDI
Class IIActive
t:slim X2 Insulin Pump with Control-IQ Technology 1013198
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (13)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Jan 30, 2026Z-1636-2026—open, classified

The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead direct users to confirm that the infusion set is not connected to the body. Following this instruction could result in unintended insulin delivery, potentially leading to a hypoglycemic event.

Oct 6, 2025Z-0427-2026—open, classified

Insulin pump includes a vibration motor that gives tactile feedback for any alerts, alarms, or malfunctions. Pump may exhibit false vibration motor failure due to a software issue causing Malfunction 12: "Pump cannot operate, the mobile app can no longer receive data from the pump. Insulin delivery and any active CGM Sessions have been stopped", which could result in hyperglycemia.

Aug 5, 2025Z-0232-2026—open, classified

A software defect in versions 7.9.0.1 and 7.10.1 of the pump software for Tandem t:slim X2 and version 7.9.0.1 of the Tandem Mobi pump with Control-IQ+ technology that are paired with a G7 sensor may result in an unexpected automatic insulin correction bolus (autobolus ) which could result in hypoglycemia.

Jul 21, 2025Z-2343-2025—open, classified

Insulin pumps manufactured with speakers from Revision A and B may malfunction ("Malfunction 16") which prevents audible alerts and causes the pumps to become inoperable and stop infusing insulin which could result in a hyperglycemic event, which may lead to injury and/or hospitalization.

Jul 3, 2025Z-2621-2025—open, classified

an app defect that occurs when the phone is set to a right-to-left language, which causes app-pump pairing issues and graphical defects, which can potentially lead to incorrect therapy decisions and subsequent hypoglycemia or hyperglycemia.

Feb 27, 2025Z-1519-2025—open, classified

A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can lead to under-delivery or over-delivery of insulin based on inaccurate result leading to severe cases of hypoglycemia or hyperglycemia.

Feb 27, 2025Z-1520-2025—open, classified

A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can lead to under-delivery or over-delivery of insulin based on inaccurate result leading to severe cases of hypoglycemia or hyperglycemia.

Mar 5, 2024Z-1609-2024—open, classified

During normal use, the mobile app version 2.7 may crash and be automatically relaunched by the iOS operating system. This cycle intermittently repeats, which leads to excessive Bluetooth communication that may result in pump battery drain and may lead to the pump shutting down sooner than typically expected. Pump shutdown will cause insulin delivery to suspend, which could lead to an under-delivery of insulin and may result in hyperglycemia, including severe hyperglycemia.

May 24, 2022Z-1812-2022—open, classified

Insulin pumps may have the following issues: 1) Malfunction 6 Non-Volatile Memory, 2) Inaccurate (Fluctuating) Battery Life Display, 3) Touchscreen Staying On, 4) Unexpected Open Loop, that can be mitigated with a software update. Issues could result in hypoglycemia, hyperglycemia or diabetic ketoacidosis.

May 24, 2022Z-1811-2022—open, classified

Insulin pumps may have the following issues: 1) Malfunction 6 Non-Volatile Memory, 2) Inaccurate (Fluctuating) Battery Life Display, 3) Touchscreen Staying On, 4) Unexpected Open Loop, that can be mitigated with a software update. Issues could result in hypoglycemia, hyperglycemia or diabetic ketoacidosis.

Sep 10, 2020Z-1258-2022—open, classified

Insulin pumps may display unexpected fluctuation of the remaining battery life so ensure pump battery life does not fall below 25% remaining power. If the battery life drops to less than 5%, insulin delivery will continue for 30 minutes and then the pump will power off and insulin delivery will stop. If the battery reaches 1%, then insulin delivery will stop, which could lead to hyperglycemia.

Apr 23, 2018Z-2471-2018—open, classified

The fuel gauge, the component that reads and reports the battery parameters to the pump, could provide inaccurate readings, which present to the user in one of two ways: A) by triggering a Malfunction 4 Alarm, or B) by triggering a succession of notifications prior to the pump shutting off, including Alert 2 (Battery Low), Alert 3 (Battery Very Low) and Alarm 12 (Battery Very Low). The alarms in both scenarios notify the user that the pump has stopped delivering insulin.

Jan 10, 2014Z-0827-2014—terminated

Specific lots of insulin cartridges that are used with the T:slim Insulin Pump may be at risk for leaking. A cartridge leak could result in the device delivering too much or too little insulin, which can lead to a serious adverse event.